A short history of anti-rheumatic therapy - VII. Biological agents
The introduction of biological agents has been a major turning-point in the treatment of rheumatic diseases, particularly in rheumatoid arthritis. This review describes the principle milestones that have led, through the knowledge of the structure and functions of nucleic acids, to the development o...
Main Authors: | B. Gatto, P. Marson, G. Pasero |
---|---|
Format: | Article |
Language: | English |
Published: |
PAGEPress Publications
2011-11-01
|
Series: | Reumatismo |
Subjects: | |
Online Access: | http://www.reumatismo.org/index.php/reuma/article/view/537 |
Similar Items
-
A short history of anti-rheumatic therapy - VI. Rheumatoid arthritis drugs
by: G. Pasero, et al.
Published: (2011-09-01) -
Pharmacovigilance of Biopharmaceuticals in Rheumatic Diseases, Adverse Events, Evolution, and Perspective: An Overview
by: Sandra Rodríguez, et al.
Published: (2020-08-01) -
Biologic Targeting: New and Effective Therapeutic Approaches against Severe Asthma
by: Xin Yang, et al.
Published: (2018-01-01) -
Rho GTPase signaling in rheumatic diseases
by: Ruijie Zeng, et al.
Published: (2022-01-01) -
DEVELOPMENTS OF RUSSIAN ORIGINAL BIOLOGICAL AGENTS FOR THE TREATMENT OF IMMUNOINFLAMMATORY RHEUMATIC DISEASES
by: E. L. Nasonov, et al.
Published: (2017-04-01)